Data / Drug companies / Pioneer Life Sciences, LLC
Pioneer Life Sciences, LLC: 77 products in the FDA NDC directory, labeler code 72090
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Pioneer Life Sciences, LLC (labeler code 72090) lists 77 products in the FDA National Drug Code Directory, covering 31 finished drugs by generic name. By type: 68 over the counter drugs, 9 drugs for further processing. Its main marketing category is over the counter monograph drugs. The newest product started marketing on August 12, 2026.
The request: Watch Pioneer Life Sciences, LLC (FDA labeler code 72090): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 72090
- Products in commercial distribution
- 77
- Packages
- 90
- Finished drugs by generic name
- 31
- Prescription products
- 0
- Over the counter products
- 68
- Flagged as original packager
- 61 of 61 products that carry the flag
- Started marketing in the last 12 months
- 18
- Products with a marketing end date set
- 1
- Earliest marketing start
- June 29, 2020
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 49 | 63.6% |
| Generic drugs (ANDA) | 17 | 22.1% |
| Drugs for further processing | 9 | 11.7% |
| Other unapproved drugs | 2 | 2.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 68 | 88.3% |
| Drugs for further processing | 9 | 11.7% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 49 | 63.6% |
| Capsule, liquid filled | 22 | 28.6% |
| Tablet, extended release | 2 | 2.6% |
| Tablet, coated | 1 | 1.3% |
| Gel | 1 | 1.3% |
| Powder, for solution | 1 | 1.3% |
| Syrup | 1 | 1.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Gencare- Pain Relief Acetaminophen | 72090-069 | Tablet | Over the counter monograph drugs | August 12, 2026 |
| Gencare-Urinary Tract Defense | 72090-065 | Tablet | Other unapproved drugs | August 10, 2026 |
| Gencare-Gas Relief | 72090-073 | Capsule, liquid filled | Over the counter monograph drugs | August 4, 2026 |
| Ibuprofen | 72090-071 | Tablet | Generic drugs (ANDA) | July 29, 2026 |
| Ibuprofen | 72090-070 | Tablet | Generic drugs (ANDA) | July 29, 2026 |
| Gencare-Urinary Pain Relief Maximum Strength | 72090-072 | Tablet | Other unapproved drugs | July 21, 2026 |
| Gencare-Allergy Relief | 72090-068 | Tablet | Generic drugs (ANDA) | June 22, 2026 |
| Allergy Relief | 72090-028 | Tablet | Generic drugs (ANDA) | April 6, 2026 |
| Gencare Long-Acting Cough Relief | 72090-063 | Capsule, liquid filled | Over the counter monograph drugs | March 24, 2026 |
| Bisacodyl | 72090-131 | Tablet, coated | Over the counter monograph drugs | March 2, 2026 |
| Gas Relief | 72090-060 | Capsule, liquid filled | Over the counter monograph drugs | February 25, 2026 |
| Gencare DayTime Cold and Flu Softgel | 72090-062 | Capsule, liquid filled | Over the counter monograph drugs | February 16, 2026 |
| Gas Relief | 72090-015 | Capsule, liquid filled | Over the counter monograph drugs | February 16, 2026 |
| Gencare Hives Relief | 72090-058 | Tablet | Generic drugs (ANDA) | January 21, 2026 |
| Mucus relief | 72090-044 | Tablet | Over the counter monograph drugs | December 23, 2025 |
| Mucus Relief | 72090-011 | Tablet, extended release | Generic drugs (ANDA) | December 22, 2025 |
| Mucus Relief | 72090-012 | Tablet, extended release | Generic drugs (ANDA) | December 4, 2025 |
| Gas Relief | 72090-014 | Capsule, liquid filled | Over the counter monograph drugs | November 19, 2025 |
| Gencare-Senna-S Softgel | 72090-054 | Capsule, liquid filled | Over the counter monograph drugs | June 30, 2025 |
| Allergy Relief Diphenhydramine HCl 25mg SoftGel | 72090-052 | Capsule, liquid filled | Over the counter monograph drugs | June 30, 2025 |
| Gencare-Allergy Relief Loratadine Tablets, 10 mg | 72090-051 | Tablet | Generic drugs (ANDA) | June 30, 2025 |
| Upset Stomach Relief-Bismuth Subsalicylate 262 mg | 72090-053 | Capsule, liquid filled | Over the counter monograph drugs | June 27, 2025 |
| Allergy relief | 72090-028 | Tablet | Generic drugs (ANDA) | June 1, 2025 |
| Simethicone 125 mg | 72090-057 | Capsule, liquid filled | Drugs for further processing | May 23, 2025 |
| Acetaminophen 325mg, dextromethorphan hydrobromide 15mg and doxylamine succinate 6.25mg | 72090-056 | Capsule, liquid filled | Drugs for further processing | May 23, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.